These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19412455)

  • 21. Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.
    Calkin CV
    Ann Med; 2019; 51(5-6):281-293. PubMed ID: 31453713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data.
    Stahl SM; Laredo S; Morrissette DA
    Ther Adv Psychopharmacol; 2020; 10():2045125320905752. PubMed ID: 32110377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and initial validation of empirically derived bipolar symptom states from a large longitudinal dataset: an application of hidden Markov modeling to the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study.
    Prisciandaro JJ; Tolliver BK; DeSantis SM
    Psychol Med; 2019 May; 49(7):1102-1108. PubMed ID: 30153871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosocial interventions for children with early-onset bipolar spectrum disorder.
    Lofthouse N; Fristad MA
    Clin Child Fam Psychol Rev; 2004 Jun; 7(2):71-88. PubMed ID: 15255173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report: Uncovering hidden glucose patterns in medicated versus unmedicated bipolar disorder and comorbid type 1 diabetes mellitus.
    Breznoscakova D; Pallayova M
    Front Endocrinol (Lausanne); 2024; 15():1354749. PubMed ID: 38419952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.
    McIntyre RS; Soczynska JK; Woldeyohannes HO; Miranda A; Vaccarino A; Macqueen G; Lewis GF; Kennedy SH
    Bipolar Disord; 2012 Nov; 14(7):697-706. PubMed ID: 23107220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric Bipolar Disorder and Mood Dysregulation: Diagnostic Controversies.
    Shain BN
    Adolesc Med State Art Rev; 2014 Aug; 25(2):398-408. PubMed ID: 27132321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancing medication adherence in patients with bipolar disorder.
    Berk L; Hallam KT; Colom F; Vieta E; Hasty M; Macneil C; Berk M
    Hum Psychopharmacol; 2010 Jan; 25(1):1-16. PubMed ID: 20041478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory biomarkers and cognitive functioning in individuals with euthymic bipolar disorder: exploratory study.
    Strawbridge R; Carter R; Saldarini F; Tsapekos D; Young AH
    BJPsych Open; 2021 Jul; 7(4):e126. PubMed ID: 36043690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transitioning to bipolar disorder: A systematic review of prospective high-risk studies.
    Keramatian K; Chakrabarty T; Saraf G; Yatham LN
    Curr Opin Psychiatry; 2022 Jan; 35(1):10-21. PubMed ID: 34812740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Korean Medication Algorithm Project for Bipolar Disorder 2022, Fifth Revision: An Executive Summary.
    Woo YS; Bahk WM; Jeong JH; Lee JG; Kim W; Sohn I; Park SY; Shim SH; Seo JS; Choo IH; Yang CM; Jung MH; Jon DI; Kim MD; Yoon BH
    Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):747-761. PubMed ID: 36263649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the psychopharmacotherapy of bipolar disorder type I.
    Sleem A; El-Mallakh RS
    Expert Opin Pharmacother; 2021 Jul; 22(10):1267-1290. PubMed ID: 33612040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances toward precision medicine for bipolar disorder: mechanisms & molecules.
    Haggarty SJ; Karmacharya R; Perlis RH
    Mol Psychiatry; 2021 Jan; 26(1):168-185. PubMed ID: 32636474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.
    McElroy SL; Altshuler LL; Suppes T; Keck PE; Frye MA; Denicoff KD; Nolen WA; Kupka RW; Leverich GS; Rochussen JR; Rush AJ; Post RM
    Am J Psychiatry; 2001 Mar; 158(3):420-6. PubMed ID: 11229983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcranial Magnetic Stimulation in Bipolar II Disorder Treatment: A Case Report.
    Tran NN; Hutto S; Thompson LR; Hawkins A
    Cureus; 2023 Sep; 15(9):e45918. PubMed ID: 37885535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early intervention in bipolar affective disorders: Why, when and how].
    Pouchon A; Fakra E; Haesebaert F; Legrand G; Rigon M; Schmitt E; Conus P; Bougerol T; Polosan M; Dondé C
    Encephale; 2022 Feb; 48(1):60-69. PubMed ID: 34565543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anatomical MRI abnormalities in bipolar disorder: do they exist and do they progress?
    Monkul ES; Malhi GS; Soares JC
    Aust N Z J Psychiatry; 2005 Apr; 39(4):222-6. PubMed ID: 15777357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent progress in the search for genes for bipolar disorder.
    Kelsoe JR
    Curr Psychiatry Rep; 1999 Dec; 1(2):135-40. PubMed ID: 11122915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unmet needs of bipolar disorder patients.
    Hajda M; Prasko J; Latalova K; Hruby R; Ociskova M; Holubova M; Kamaradova D; Mainerova B
    Neuropsychiatr Dis Treat; 2016; 12():1561-70. PubMed ID: 27445475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mixed States in Bipolar Disorder: Etiology, Pathogenesis and Treatment.
    Muneer A
    Chonnam Med J; 2017 Jan; 53(1):1-13. PubMed ID: 28184334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.